Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Magenta Therapeutics Inc (MGTA)

Magenta Therapeutics Inc (MGTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Magenta Therapeutics Inc 300 Technology Square 8th Floor Cambridge MA 02139 USA

www.magentatx.com P: 857-242-0170

Description:

Magenta Therapeutics Inc. is a clinical-stage biotechnology company. It engaged in developing therapeutics focused on critical areas of unmet need in the field of bone marrow transplant for patients with autoimmune diseases, blood cancers and genetic diseases. Magenta Therapeutics Inc. is headquartered in Cambridge, Mass.

Key Statistics

Overview:

Market Capitalization, $K 42,441
Enterprise Value, $K -69,609
Shares Outstanding, K 60,665
Annual Sales, $ 0 K
Annual Net Income, $ -76,460 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,280 K
EBIT, $ -78,490 K
EBITDA, $ -76,560 K
60-Month Beta 2.12
% of Insider Shareholders 11.56%
% of Institutional Shareholders 47.53%
Float, K 53,652
% Float 88.44%
Short Volume Ratio 0.24

Growth:

1-Year Return -63.75%
3-Year Return -90.94%
5-Year Return -93.82%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.05 on 08/03/23
Latest Earnings Date 11/02/23
Earnings Per Share ttm -0.32
EPS Growth vs. Prev Year 82.76%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-16 on 09/12/23

MGTA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -70.88%
Return-on-Assets % -57.27%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.57
Book Value/Share 1.23
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar